IL136911A0 - Heterocyclic topoisomerase poisons - Google Patents

Heterocyclic topoisomerase poisons

Info

Publication number
IL136911A0
IL136911A0 IL13691198A IL13691198A IL136911A0 IL 136911 A0 IL136911 A0 IL 136911A0 IL 13691198 A IL13691198 A IL 13691198A IL 13691198 A IL13691198 A IL 13691198A IL 136911 A0 IL136911 A0 IL 136911A0
Authority
IL
Israel
Prior art keywords
sub
compounds
heterocyclic
group
topoisomerase poisons
Prior art date
Application number
IL13691198A
Other languages
English (en)
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of IL136911A0 publication Critical patent/IL136911A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13691198A 1997-12-31 1998-12-30 Heterocyclic topoisomerase poisons IL136911A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7028797P 1997-12-31 1997-12-31
PCT/US1998/027822 WO1999033824A1 (en) 1997-12-31 1998-12-30 Heterocyclic topoisomerase poisons

Publications (1)

Publication Number Publication Date
IL136911A0 true IL136911A0 (en) 2001-06-14

Family

ID=22094368

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13691198A IL136911A0 (en) 1997-12-31 1998-12-30 Heterocyclic topoisomerase poisons

Country Status (11)

Country Link
US (3) US6667302B2 (xx)
EP (1) EP1044199B1 (xx)
JP (1) JP2002509858A (xx)
CN (1) CN1299358A (xx)
AT (1) ATE402168T1 (xx)
AU (1) AU753268B2 (xx)
CA (1) CA2316221A1 (xx)
DE (1) DE69839781D1 (xx)
IL (1) IL136911A0 (xx)
PL (1) PL341539A1 (xx)
WO (1) WO1999033824A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839781D1 (en) * 1997-12-31 2008-09-04 Univ Rutgers Heterocyclische topoisomerase toxine
CN1829709A (zh) * 2003-08-01 2006-09-06 健亚生物科技公司 对抗黄病毒的双环咪唑衍生物
CA2593450A1 (en) * 2005-01-14 2006-07-20 Genelabs Technologies, Inc. Indole derivatives for treating viral infections
AU2006218403A1 (en) 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Fused heterocyclic compounds and their use as sirtuin modulators
US8093401B2 (en) 2005-08-04 2012-01-10 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
US7855289B2 (en) 2005-08-04 2010-12-21 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
CA2618360C (en) 2005-08-04 2015-06-09 Sirtris Pharmaceuticals, Inc. Benzothiazoles and thiazolopyridines as sirtuin modulators
US8088928B2 (en) 2005-08-04 2012-01-03 Sirtris Pharmaceuticals, Inc. Sirtuin modulating compounds
WO2008073451A2 (en) * 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
TW200916472A (en) 2007-06-20 2009-04-16 Sirtris Pharmaceuticals Inc Sirtuin modulating compounds
EA021424B1 (ru) 2008-12-19 2015-06-30 Сертрис Фармасьютикалз, Инк. Тиазолопиридиновые соединения, регулирующие сиртуин
AU2016267606B2 (en) 2015-05-28 2022-04-14 Ecolab Usa Inc. 2-substituted imidazole and benzimidazole corrosion inhibitors
US10519116B2 (en) 2015-05-28 2019-12-31 Ecolab Usa Inc. Water-soluble pyrazole derivatives as corrosion inhibitors
JP6849608B2 (ja) * 2015-05-28 2021-03-24 エコラボ ユーエスエー インコーポレイティド 新規腐食抑制剤
US10669637B2 (en) 2015-05-28 2020-06-02 Ecolab Usa Inc. Purine-based corrosion inhibitors

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE26065E (en) 1966-07-19 Folybenzimidazoles and their preparation
US26065A (en) 1859-11-08 Improvement in cotton-gins
US2985661A (en) 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
CH420044A (de) 1964-09-01 1967-03-15 Ciba Geigy Verwendung von neuen Azol-Derivaten als optische Aufheller für textile organische Materialien
DE1670684A1 (de) * 1966-04-01 1970-12-03 Hoechst Ag Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten
SU1530628A1 (ru) 1987-11-20 1989-12-23 Ленинградский Технологический Институт Им.Ленсовета Тригидрохлорид 2-[2-фенил-5(6)-бензимидазолил]-N-(3-диметиламинопропил)-5(6)-бензимидазолкарбоксамида в качестве флуоресцентного красител дл исследовани ДНК
JP2700475B2 (ja) 1988-07-30 1998-01-21 コニカ株式会社 非線形光学材料および非線形光学素子
US5106863A (en) 1990-03-26 1992-04-21 Ortho Pharmaceutical Corporation Substituted imidazole and pyridine derivatives
US5767142A (en) 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
CA2221248A1 (en) * 1995-05-17 1996-11-21 Leroy Fong Liu Tribenzimidazoles useful as topoisomerase i inhibitors
US5807874A (en) 1995-05-17 1998-09-15 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
US5770617A (en) 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
DE69839781D1 (en) * 1997-12-31 2008-09-04 Univ Rutgers Heterocyclische topoisomerase toxine
US6063801A (en) * 1998-02-12 2000-05-16 Rutgers, The State University Of New Jersey Heterocyclic topoisomerase poisons

Also Published As

Publication number Publication date
AU753268B2 (en) 2002-10-10
WO1999033824A1 (en) 1999-07-08
PL341539A1 (en) 2001-04-23
US20080004280A1 (en) 2008-01-03
EP1044199A1 (en) 2000-10-18
DE69839781D1 (en) 2008-09-04
EP1044199B1 (en) 2008-07-23
US6667302B2 (en) 2003-12-23
JP2002509858A (ja) 2002-04-02
AU2022099A (en) 1999-07-19
US20020151575A1 (en) 2002-10-17
CA2316221A1 (en) 1999-07-08
US6995154B2 (en) 2006-02-07
ATE402168T1 (de) 2008-08-15
US20040082637A1 (en) 2004-04-29
CN1299358A (zh) 2001-06-13

Similar Documents

Publication Publication Date Title
IL136911A0 (en) Heterocyclic topoisomerase poisons
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
DE59308619D1 (de) Germicide wirkstoffkombinationen
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
ES2191260T3 (es) Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos.
EA200100983A1 (ru) Производные 13-метилэритромицина
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
ATE156818T1 (de) Polyfluoralkylthiopoly(ethylimidazolium)- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als biozide mittel
AU3265595A (en) Quinazoline derivative
WO2003063787A3 (en) Non-steroidal analogs of 2-methoxyestradiol
EP1228072A4 (en) PDGF RECEPTOR KINASE INHIBITING COMPOUNDS, THEIR PRODUCTION, CLEANING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
EE200000472A (et) Kasvajavastased toimeained
ATE172463T1 (de) Pyrrolocarbazol
AU9066498A (en) Substituted 6-alkylphenanthridines
DK0696585T3 (da) Nyt bisoxadiazolidinderivat
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
TR199900153T2 (xx) H�cre �o�almas�n� �nlemek i�in ikame edilmi� bisindolilmaleimitler.
DE69330601T2 (de) Serotoninergische ergolin derivate
FR2677983B1 (fr) Composes alkylthiopoly(ethylimidazolium), procede de preparation et leur utilisation comme agents biocides.
DE69900297D1 (de) Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung
BR9508979A (pt) Carboxamidas bicíclicas como antagonistas de 5-ht1a
EA200001157A2 (ru) Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
WO2001019185A3 (en) Methods for controlling a pest population
MX9702941A (es) Compuestos de di-ter - butilfenol que tiene una porcion heterociclica, utiles como agentes anti-inflamatorios.
MY103817A (en) Chloroaniline derivatives